Related Experiment Video

Updated: May 22, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy

Lei Qiu1, Xi Gong, Qianli Wang

  • 1School of Pharmacy, Second Military Medical University, Shanghai, 200433, China.

Cancer Immunology, Immunotherapy : CII
|April 28, 2012
PubMed

Insights

This study introduces a novel cancer immunotherapy strategy using artificial tumor-associated carbohydrate antigen (TACA) derivatives and metabolic glycoengineering. This approach enhances TACA immunogenicity, leading to significant tumor suppression and improved survival in preclinical models.

Area of Science:

  • Immunology
  • Oncology
  • Carbohydrate Chemistry

Background:

  • Tumor-associated carbohydrate antigens (TACAs) are promising targets for cancer vaccines and immunotherapies.
  • A significant challenge is the poor immunogenicity of TACAs, limiting their therapeutic efficacy.

Purpose of the Study:

  • To develop a novel cancer immunotherapeutic strategy by combining synthetic TACA derivatives with metabolic glycoengineering.
  • To enhance the immunogenicity of TACAs and improve cancer treatment outcomes.

Main Methods:

  • Exploration of a new strategy using artificial TACA derivatives (GM3NPhAc) and metabolic glycoengineering precursor (ManNPhAc).
  • Utilized a murine leukemia model (FBL3) targeting the GM3 antigen.
  • Evaluated antigen-specific T cell immunity, cancer cell glycoengineering, antibody-mediated cytotoxicity, and in vivo tumor suppression.

Main Results:

  • The artificial GM3 N-phenylacetyl derivative (GM3NPhAc) induced robust T cell-dependent immunity.
  • N-phenylacetyl-D-mannosamine (ManNPhAc) effectively glycoengineered FBL3 cancer cells to express GM3NPhAc.
  • GM3NPhAc-specific antibodies demonstrated potent cytotoxicity against treated cancer cells.
  • Vaccination with GM3NPhAc followed by ManNPhAc treatment significantly suppressed tumor growth and prolonged survival in mice.

Conclusions:

  • The developed cancer immunotherapy strategy is feasible and effective.
  • This approach holds general significance for cancer treatment by overcoming TACA immunogenicity and achieving tumor cure.

More Related Videos

Hierarchical and Programmable One-Pot Oligosaccharide Synthesis09:56

Hierarchical and Programmable One-Pot Oligosaccharide Synthesis

Published on: September 6, 2019

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...